Genentech Joins Hunt For ‘Molecular Glue’ Drugs With Orionis

Will Aim At ‘Undruggable’ Oncology and Neurodegeneration Targets

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.